Reject ‘Big 3’ health fund increases over 3%, evidence shows

18 November, 2019

The ‘Big 3’ corporate health funds have no reason to raise their prices more than 3 per cent next year, new evidence shows, with the Federal regulator APRA urged to reject any that do.

Joint statement on the Research & Development Tax Incentive

18 April, 2017

The Medical Technology Association of Australia (MTAA) has joined fellow organisations AusBiotech, Research Australia, Medicines Australia & BioMelbourne Network in a joint statement urging the Federal Government not to devastate Australia’s most innovative industry by gutting the Research & Development (R&D) Tax Incentive.

text
Member

MTAA seeking member feedback on potential items for expanded Prostheses List

  • 10 Jul 2019
  • Position papers
Video
Registered

PL Reform Industry Webinar – Government/MTAA MOU Webinar Recording

  • 24 Mar 2022
  • Position papers

Medical Technology industry welcomes balanced Prostheses List Report

12 May, 2017

The Medical Technology Association of Australia (MTAA) today welcomed the findings of the Senate Inquiry into the price regulation associated with the Prostheses List Framework.  Last year in Australia more than 2.5 million surgeries took place, and for each and every one of these surgeries innovative medical technology played a part.  As the committee report itself states, medical devices account for only 14 cents in every dollar paid in private health insurance reimbursements.  Overall, spending on life enhancing medical devices accounts for only 1.2% of the entire Australian health budget.  The Senate Committee report clearly reflected the complexity of the issues involved in medical device pricing and rejected the slash and burn approach advocated by the private health insurers.  The recommendations of the report are sensible and MTAA supports them.

File
Public

Procurement survey results

  • 25 Sep 2019
  • Sponsorship

Prostheses Reform Updates

18 January, 2023

The Federal Minister Mark Butler announced on 14 December that funding arrangements for General Use items to be removed from the Prostheses List (PL) 1 July 2022 would be mandatory. At the same time, the Independent Hospital Pricing Authority released its advice on funding for these General Use items.

Therapeutic Development a key focus of the Roadmap

15 May, 2017

The Medical Technology Association of Australia (MTAA) welcomes the 2016 National Research Infrastructure Roadmap and its recommendations, in particular around the need to increase capacity to develop new therapies or medical devices.

File
Public

Procurement survey results

  • 25 Sep 2019
  • Sponsorship

Important Notice on Prostheses List Applications

26 April, 2023

Significant changes to the upcoming 14 May application deadline for the 1 November Prostheses List. Recommend taking action early.